These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12765206)

  • 1. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome.
    Ross S; Dermatis H; Levounis P; Galanter M
    Am J Drug Alcohol Abuse; 2003 May; 29(2):263-79. PubMed ID: 12765206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personality disorders prevalence study among inpatients with mood disorders, psychoactive use disorders and anxiety disorders].
    Marinangeli MG; Butti G; Scinto A; Di Cicco L; Kalyvoka A; Petruzzi C; Rossi A
    Epidemiol Psichiatr Soc; 2000; 9(1):36-44. PubMed ID: 10859874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Personality disorders in a clinical sample of Cannabis dependent young adults].
    Watzke AB; Schmidt CO; Zimmermann J; Preuss UW
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):600-5. PubMed ID: 18833505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance dependence and personality disorders: comorbidity and treatment outcome in an inpatient treatment population.
    Thomas VH; Melchert TP; Banken JA
    J Stud Alcohol; 1999 Mar; 60(2):271-7. PubMed ID: 10091966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
    Skodol AE; Oldham JM; Gallaher PE
    Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity.
    Jahng S; Trull TJ; Wood PK; Tragesser SL; Tomko R; Grant JD; Bucholz KK; Sher KJ
    J Abnorm Psychol; 2011 Aug; 120(3):656-69. PubMed ID: 21604829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth study of personality disorders in first-admission patients with substance use disorders.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2012 Oct; 12():180. PubMed ID: 23107025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
    Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
    Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity.
    Barrachina J; Pascual JC; Ferrer M; Soler J; Rufat MJ; Andión O; Tiana T; Martín-Blanco A; Casas M; Pérez V
    Compr Psychiatry; 2011; 52(6):725-30. PubMed ID: 21349508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity in adolescent inpatients with substance use disorders.
    Grilo CM; Becker DF; Walker ML; Levy KN; Edell WS; McGlashan TH
    J Am Acad Child Adolesc Psychiatry; 1995 Aug; 34(8):1085-91. PubMed ID: 7665447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personality disorders and associated features in cocaine-dependent inpatients.
    Kranzler HR; Satel S; Apter A
    Compr Psychiatry; 1994; 35(5):335-40. PubMed ID: 7995024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a sociological framework for dually diagnosed women.
    Palacios WR; Urmann CF; Newel R; Hamilton N
    J Subst Abuse Treat; 1999; 17(1-2):91-102. PubMed ID: 10435256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality disorders and Axis I comorbidity in adolescent outpatients with ADHD.
    Korsgaard HO; Torgersen S; Wentzel-Larsen T; Ulberg R
    BMC Psychiatry; 2016 Jun; 16():175. PubMed ID: 27245754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of personality disorders in a Kenyan inpatient sample.
    Thuo J; Ndetei DM; Maru H; Kuria M
    J Pers Disord; 2008 Apr; 22(2):217-20. PubMed ID: 18419240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurrence of Axis I and Axis II disorders in substance abusers.
    Verheul R; Kranzler HR; Poling J; Tennen H; Ball S; Rounsaville BJ
    Acta Psychiatr Scand; 2000 Feb; 101(2):110-8. PubMed ID: 10706010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use disorders and Cluster B personality disorders: physiological, cognitive, and environmental correlates in a college sample.
    Taylor J
    Am J Drug Alcohol Abuse; 2005; 31(3):515-35. PubMed ID: 16161732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar obsessive-compulsive disorder and personality disorders.
    Maina G; Albert U; Pessina E; Bogetto F
    Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.